Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812912 · ClinicalTrials.gov registry record
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
A clinical trial of Colorectal Cancer and Colorectal Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 120
- Enrollment target
- 7
- Study locations
NCT04812912 is a study of Colorectal Cancer and Colorectal Neoplasms that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 120 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 2 states.
The verdict
NCT04812912, a study of Colorectal Cancer and Colorectal Neoplasms, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Hormone biomarker analysis
- BEHAVIORAL QoL Questionnaires
Study Locations (7)
New York
- Memorial Sloan Kettering Cancer Center at Suffolk - Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2026-03-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04812912
The ClinicalTrials.gov registry entry for NCT04812912 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Hormone biomarker analysis is the first listed.
NCT04812912 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04812912 about?
NCT04812912 is a clinical study titled "Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer". The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in p...
What is the current status of trial NCT04812912?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2021-03-18. Estimated completion is 2026-03-18.
What conditions does trial NCT04812912 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma.
What interventions are being tested in trial NCT04812912?
The interventions under investigation include: Hormone biomarker analysis (DIAGNOSTIC_TEST), QoL Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT04812912?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04812912 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.